Concepedia

Pharmacogenomic Determinants of the Cardiovascular Effects of Dalcetrapib

Jean‐Claude Tardif, Éric Rhéaume, Louis‐Philippe Lemieux Perreault, Jean C. Grégoire, Yassamin Feroz Zada, Géraldine Asselin, Sylvie Provost, Amina Barhdadi, David Rhainds, Philippe L. L’Allier,

Circulation Cardiovascular Genetics · 2015 · 183 citations · 19 references

DOI

Abstract

URL: http://www.clinicaltrials.gov. Unique identifiers: NCT00658515 and NCT01059682.

References

19

Effects of Torcetrapib in Patients at High Risk for Coronary Events

Philip J. Barter, Mark J. Caulfield, Mats Eriksson et al. · New England Journal of Medicine · 2007 · 3.1K citations · Full text

Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy

New England Journal of Medicine · 2011 · 2.9K citations · Full text

Rare-Variant Association Testing for Sequencing Data with the Sequence Kernel Association Test

Michael C. Wu, Seunggeun Lee, Tianxi Cai et al. · The American Journal of Human Genetics · 2011 · 2.5K citations · Full text

, , +12

A linear complexity phasing method for thousands of genomes

Olivier Delaneau, Jonathan Marchini, Jean‐François Zagury · Nature Methods · 2011 · 2K citations

, , +9

Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome

Gregory G. Schwartz, Anders Olsson, Markus Abt et al. · New England Journal of Medicine · 2012 · 2K citations · Full text